For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

"Autologous Stem Cell Transplantation Proven Beneficial for Older Patients with Multiple Myeloma"... 4-Year Survival Rate Up ...

David Bongomin Awany was preparing to leave Uganda for India when his treatment plan suddenly changed. The 56-year-old businessman from Nwoya district, now living in Gulu City, had been diagnosed with ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging survival. Patients are living years longer, thanks to novel combination therapies ...

A Rochester firefighter who donated stem cells to a Tennessee woman battling cancer met her for the first time in Chicago, nearly two years after becoming her match.

Please provide your email address to receive an email when new articles are posted on . Research has shown that autologous hematopoietic stem cell transplantation is an effective treatment for MS. At ...

Autologous haematopoietic stem cell transplantation (AHSCT) has emerged as a potent therapeutic approach for severe, treatment-refractory autoimmune diseases. By harvesting a patient’s own ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

Elderly patients with multiple myeloma should not be excluded from autologous hematopoietic stem cell transplantation based on age alone, according to a new dom ...

NICE also endorsed an MRD‑guided approach, allowing daratumumab to be stopped after at least 24 months of maintenance if MRD remains negative for at least 12 months. Scott Purdon, Head of Patient ...